ENDRA Life Sciences
Ann Arbor, Michigan, 48105, United States
Location status: Recruiting
Location contact
Ava Ohlgren
CONTACT
Chris Bull
CONTACT
NCT Number: NCT07321925
The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Ann Arbor, Michigan, 48105, United States
Location status: Recruiting
Ava Ohlgren
CONTACT
Chris Bull
CONTACT
The study will perform thermoacoustic fat measurements for up to 80 participants, over the span of the study. MRI-PDFF sequences will be acquired for participants in the study to establish a true measure of liver fat content, per the MRI gold standard. Determine the correlation between FLIP CID system Fat fraction results and the MRI-PDFF. Determine the accuracy between the fat measures obtained by the FLIP CID system participants who received a quantitative MRI. The following additional parameters will be evaluated endpoints: Sensitivity, Specificity ,Positive and negative predictive value (PPV, NPV) and The area under the ROC curve for the detection of liver fat abnormalities
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a novel Thermoacoustic Enhanced imaging device
Time frame: From enrollment until the statistical analysis is reviewed, typically 2 weeks after last MRI data is received.
The correlation between TAFF and the MRI-PDFF, will be conducted using the calculation of the cumulative distribution of the correlation coefficient as derived by Guenther
Contact information is provided by the study sponsor or research team.
Ava Ohlgren
CONTACT
Ziad Rouag
CONTACT
Endra Lifesciences
Industry
Thermoacoustic Method for Estimating Liver Fat Fraction - Pilot Study I
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03938246
Digestive System Diseases, Fatty Liver
Chula Vista, California, United States
View Trial DetailsNCT07070362
ARDS, Human, Acute Lung Injury
Beijing, Beijing Municipality, China
View Trial DetailsNCT07330830
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Cayenne, French Guiana
View Trial DetailsNCT07280143
Breast Cancer Survivors, Colorectal (Colon or Rectal) Cancer Survivors
Bern, Switzerland
View Trial Details